GLP-1s, which have been used for years to treat Type 2 diabetes, have gained widespread attention as a way to lose weight and reduce obesity-related conditions and their long-term costs
Methods: This was a retrospective cohort study using data from the Veterans Health Administration
Initial anecdotal reports are promising, but we still need more long data to form conclusions, Katie Robinson, an assistant professor at the University of Iowa, told me
This delayed gastric emptying is central to both the therapeutic effect and the side effect profile of these injections
Studies have shown that patients on these medications, combined with lifestyle changes, can achieve substantial weight loss, often in the range of 15% to over 20% of their total body weight, making them a powerful tool in the fight against obesity
Despite this, low-dose semaglutide was associated with a significant reduction in alcohol consumption over 2 months